Article (Scientific journals)
Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease
Spathis, Athanasios; Asvos, Xenophon; Ziavra, Despina et al.
2017In Proceedings of the National Academy of Sciences of the United States of America
Peer Reviewed verified by ORBi
 

Files


Full Text
2017_Spathis.pdf
Publisher postprint (1.79 MB)
Request a copy

All documents in ORBilu are protected by a user license.

Send to



Details



Disciplines :
Life sciences: Multidisciplinary, general & others
Author, co-author :
Spathis, Athanasios
Asvos, Xenophon
Ziavra, Despina
Karampelas, Theodoros
Topouzis, Stavros
Cournia, Zoe
QING, Xiaobing ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB)
Alexakos, Pavlos
SMITS, Lisa ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB)
Dalla, Christina
Rideout, Hardy
SCHWAMBORN, Jens Christian ;  University of Luxembourg > Faculty of Science, Technology and Communication (FSTC) > Life Science Research Unit
Tamvakopoulos, Constantin
Fokas, Demosthenes
Vassilatis, Demetrios
More authors (5 more) Less
External co-authors :
yes
Language :
English
Title :
Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease
Publication date :
2017
Journal title :
Proceedings of the National Academy of Sciences of the United States of America
ISSN :
1091-6490
Publisher :
National Academy of Sciences, Washington, United States - District of Columbia
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBilu :
since 14 April 2017

Statistics


Number of views
135 (6 by Unilu)
Number of downloads
2 (1 by Unilu)

Scopus citations®
 
59
Scopus citations®
without self-citations
55
OpenCitations
 
53
WoS citations
 
59

Bibliography


Similar publications



Contact ORBilu